Skip to main content
Signal8

TYAGI ASHU

SEC insider (Form 3/4/5 filer). CIK 0001752467. Director at Y-mAbs Therapeutics, Inc. (YMAB). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2025. Located in NEW YORK, NY.

Companies TYAGI ASHU has filed insider reports for

  • Y-mAbs Therapeutics, Inc. (YMAB): Director
TYAGI ASHU profile photo

TYAGI ASHU

CIK: 0001752467

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Y-mAbs Therapeutics, Inc. logo
YMAB

Y-mAbs Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Y-mAbs Therapeutics, Inc. logo
    YMAB

    Y-mAbs Therapeutics, Inc.

    Sep 16, 2025
    Tender Offer
    Direct
    5.8K shares at avg. $8.60$50K
  • Y-mAbs Therapeutics, Inc. logo
    YMAB

    Y-mAbs Therapeutics, Inc.

    Sep 16, 2025
    Disposition
    Direct
    25.1K shares-
  • Y-mAbs Therapeutics, Inc. logo
    YMAB

    Y-mAbs Therapeutics, Inc.

    Jun 30, 2025
    Award
    Direct
    25.1K shares-

1-3 of 3